関連する実験動画
Updated: Jan 9, 2026
01:27
Pulmonary Embolism III: Nursing Management
Published on: June 19, 2025
320
MAPK媒介のバイモダル遺伝子発現と,酵母菌における適応的グラデントセンシング
Saurabh Paliwal1, Pablo A Iglesias, Kyle Campbell
1Department of Biomedical Engineering and Whitaker Institute of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland 21218, USA.
Nature
|February 21, 2007
まとめ
研究者は微流体学とモデリングを使用して,酵母の交配経路を探索しました. 彼らはスイッチのような分級反応を発見し,キナーゼKss1が遺伝子発現の感受性と交配中のグラデーション感知に不可欠である.
科学分野:
- 細胞生物学 細胞生物学
- システム生物学 システム生物学
- 遺伝学 遺伝学とは
背景:
- Saccharomyces cerevisiaeの交配経路は複雑で,多くの定量的な規制的側面がまだ完全に理解されていない.
- 制御された条件下で遺伝子発現とフェノタイプの変化を理解することは,経路の動態を解明するために重要である.
研究 の 目的:
- Saccharomyces cerevisiaeの交配経路調節の定量的な側面を調査する.
- 遺伝子の発現とフェノタイプの変化を,定義されたフェロモングラデーションに反応して分析する.
- 交配経路の調節におけるミトゲン活性化タンパク質キナーゼ (MAPK) 信号伝達および転写因子Ste12の役割を明らかにする.
主な方法:
- マイクロ流体チップ実験とコンピューティングモデリングを組み合わせた統合アプローチ.
- よく定義されたフェロモングラデーションの下で遺伝子発現とフェノタイプの変化を研究した.
- Kss1欠乏変異体を含む遺伝分析を用いて,キナーゼ機能の評価を行った.
主要な成果:
- スイッチのような反応とグレードされた経路の反応の組み合わせが観察され,特定のフェロモン濃度範囲内のストキャスティック現象型決定につながった.
- MAPK媒介によるSte12活動とSte12自己調節フィードバックの調節に重大な依存性を示した.
- Kss1欠乏は,スイッチのような特性,遺伝子発現の感受性,グラデントセンシングのダイナミックレンジを著しく低下させることを発見しました.
結論:
- イーストの交配反応は,スイッチのような反応と分級反応の両方を含む複雑な規制ダイナミクスを示しています.
- ミトゲン活性化タンパク質キナーゼ (MAPK) 信号伝達,特にKss1を通じて,Ste12活性とフェロモン反応の感受性を調節する上で,これまで疑われなかった重要な役割を果たしています.
- Kss1は,Saccharomyces cerevisiaeの交配過程中の敏感なグラデント感知と堅固な遺伝子発現調節に不可欠です.
関連する概念動画
Pulmonary Embolism III: Nursing Management
320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction
464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II
852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K